Filing Details
- Accession Number:
- 0001209191-21-038651
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-07 16:47:42
- Reporting Period:
- 2021-06-04
- Accepted Time:
- 2021-06-07 16:47:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1724521 | Arcus Biosciences Inc. | RCUS | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1671311 | Jennifer Jarrett | C/O Arcus Biosciences, Inc. 3928 Point Eden Way Hayward CA 94545 | Chief Operating Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-06-04 | 1,044 | $24.91 | 119,174 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- Includes 245 shares purchased on 5/28/2021 through the Company's Employee Stock Purchase Plan.
Billionaire Hedge Funds
